High-quality | Open Access | Immunology Research

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Open Access Immunology Research

Welcome to Taylor & Francis Open Access Immunology Research


We've created this page to provide authors and researchers with quick access to high-quality, fully open content. Open access makes published academic research freely and permanently available online: Anyone, anywhere can read and build upon this research.

Taylor & Francis hopes that by equipping researchers with relevant materials, breakthroughs in understanding healthy and diseased immune systems can occur at a quicker pace, yielding better treatment methods with advanced applications in other aspects of medicine.

Click on the links below to explore our range of open access journals in Immunology and the different specialties that collectively comprise this portfolio.

Publishing Options

We offer publishing options that meet the needs of an ever-evolving market. To learn more about the publishing options we offer, please visit our Open Access Hub.

Emerging Microbes & Infections

An open access journal | 2018 Impact Factor 6.212

The mission of Emerging Microbes & Infections ( EMI ) is to provide a new, integrated forum that allows for the timely dissemination of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.

The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and thus EMI is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years.



An open access journal | 2018 Impact Factor 5.333

OncoImmunology focuses specifically on tumor immunology. As a result of recent progress in the field, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. Concurrently, there is a need for research that explores the combination of conventional anticancer therapies with immunotherapies.

OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.


Immunological Medicine

An open access journal

Immunological Medicine encourages the submission of original manuscripts covering a wide range of topics such as rheumatology, allergology, oncology, hematology, cardiology, neurology, respiratory medicine, gastroenterology, nephrology, dermatology, pediatrics and other medical topics that relate to both basic and clinical immunology. 

Recent progress in the field of clinical immunology has been remarkable—Many diseases and conditions, including autoimmune diseases, allergy-related diseases, infectious diseases, malignant diseases, immunodeficiency and transplantation-related conditions are associated with immunological abnormalities and require immunological approaches from various medical fields.

Clinical immunology plays an increasingly important role as the bridge between basic research and clinical practice, with the significance of translational research rapidly increasing in recent years.


Journal of Immunotoxicology

An open access journal | 2018 Impact Factor 1.734

Journal of Immunotoxicology provides a much needed singular forum for the international community of immunotoxicologists, immunologists and toxicologists working in academia, government, consulting and industry to both publish their original research and to stay informed with the latest research findings of their colleagues.

Research from many sub-disciplines are presented in the journal, including the areas of molecular, developmental, pulmonary, regulatory, nutritional, mechanistic, wildlife, and environmental immunotoxicology, immunology, and toxicology. Journal of Immunotoxicology publishes original research articles as well as timely comprehensive reviews.


Microbial Ecology in Health and Disease

An open access journal

Microbial Ecology in Health and Disease is the official journal of the Society of Microbial Ecology in Health and Disease (SOMED).

The research presented in this journal has received new impetus in recent years as it has become clearer what part is played by the normal, microbial flora in preventing infection, and related to this, the potentially deleterious effects of the use of antibiotics. The aim is to draw together research on different human microbial eco-systems, and to increase our understanding of their role in health and disease.

Topics covered include:

  • Microbial populations of the mouth and skin, and in the respiratory, gastro-intestinal and genito-urinary tracts
  • Effect of antibiotics or diet on the commensal flora or its development, alterations in the host environment (e.g. the effect of foreign bodies or change in organs and tissues)
  • The role of immunological and other mechanisms that help maintain a stable flora
  • Clinical application of commensal flora in treatment and prevention of disease


Dove Medical Press

Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa Plc
Dove Press specializes in the publication of open access, peer-reviewed journals across the spectrum of science, technology and medicine. Our journals are indexed online via PubMed and PubMed Central, as well as in other notable indexing services. We publish several journals that address Immunology—from allergy & respiratory disease, immunotargets, transplant research and infection, the coverage is thorough.


Explore Taylor & Francis Immunology Journals

A high-quality portfolio with hybrid and fully open access publishing options. Our journals focus on broad, cross-discipline, regionally specific and global Immunology research.

Cogent Medicine

A home for scientifically sound, fully open access and peer-reviewed health research, Cogent Medicine, part of Taylor & Francis Group, publishes experimental, translational and clinical approaches across all areas of biomedical sciences and clinical research and practice.


F1000Research is an open research publishing platform for scientists, scholars and clinicians offering rapid publication of articles and other research outputs. All articles benefit from transparent peer-review and the inclusion of all source data.